Formed in 1971, the DMDG is an informal World-wide association for scientists engaged in research and development within the drug metabolism, pharmacokinetics and related disciplines of the pharmaceutical industry. In 2022, our membership now spans 30 countries across 4 continents comprising pharma/biotech (60%), CRO (20%), academic institutions (8%) and technology companies (4%) with the remainder made up from consultants and regulatory authorities.
Membership of the DMDG is FREE and by company site although individuals who work at a member site can sign up to receive information about DMDG meetings and training courses. Applications for membership are considered by a Management Committee that conducts the business of the DMDG.
Members who have made outstanding contributions, long term commitment and high-level service to the DMDG shall be eligible for DMDG Fellow status. Fellows belong to a distinguished category of membership who have the privilege of membership without site-based representation.
The DMDG organises training courses and scientific meetings for the benefit of its membership. In addition, the DMDG encourages participation from new practitioners in the field of Drug Metabolism and Pharmacokinetics by offering free places at the annual Open Meeting to final year PhD students in these areas of research. Members of the DMDG contribute to many publications, not least of these is Xenobiotica, a peer-reviewed medical journal that publishes comprehensive research papers on all areas of xenobiotics.
The DMDG is committed to maintaining high standards of conferences and training courses, whilst also maintaining a positive and supportive environment for all. We aspire to ensure that everyone involved with the DMDG is equally valued and respected. As a facilitator of scientific discussion, collaboration and training, we value the diversity of our committee members, fellows, course tutors and members. We are committed to providing a fair, equitable and mutually supportive environment for all. This is reflected in the core values of our strategy, which state the importance of:
Valuing, respecting and promoting the rights, responsibilities and dignity of individuals within all our activities and relationships.
Equality of opportunity based on merit, irrespective of background, beliefs and socio-economic context